Published today in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders is a new original research article by J Al-Bishri, SM Attar, Nawal Bassuni, Yasser Al-Nofaiey, Hamed Qutbuddeen, Salma Al-Harthi and Sarah Subahi.  Read more about this paper below:

Title

Comorbidity Profile Among Patients with Rheumatoid Arthritis and the Impact on Prescriptions Trend

Abstract

Comorbid conditions play a pivotal role in rheumatoid arthritis management and outcomes. We estimated the percentage of comorbid illness among rheumatoid arthritis patients and explored the relationship between this comorbidity and different prescriptions. A cross-sectional study of patients with rheumatoid arthritis in three centers in Saudi Arabia was carried out. Comorbidity and antirheumatoid medication regimens prescribed were recorded on a specially designed Performa. The association between comorbidity and different drugs was analyzed. A total of 340 patients were included. The most comorbidities were hypertension 122 (35.9%), diabetes 105 (30.9%), osteoporosis 88 (25.8%), and dyslipidemia in 66 (19.4). The most common drug prescribed was prednisolone in 275 (80.8%) patients followed by methotrexate in 253 (74.4%) and biological therapy in 142 (41.5%) patients. Glucocorticoids were prescribed considerably more frequently in hypertensive and diabetic patients as well as in patients with osteoporosis and dyslipidemia. Most patients with rheumatoid arthritis suffered from comorbid diseases.

Click here to learn more about the article, download it and comment

share on